The Genomics of Common Diseases
Nature Genetics in association with The Wellcome Trust is pleased to announce the second Genomics of Common Diseases meeting.
The Genomics of Common Diseases 2008
September 6-9, 2008, The Broad Institute of MIT and Harvard, Cambridge, MA, USA
The meeting is now at capacity.
The availability of whole genome association studies has redefined the genetic architecture of genetically complex disorders, and over the next few years, genotyping and resequencing will reveal new susceptibility genes for a wide range of common human diseases. This is shifting the strategic emphasis of common disease genetics, from identification of susceptibility genes to understanding of mechanisms and potential applications.
Following the successful inaugural conference in Hinxton, Cambridge, UK in July 2007, this second meeting will aim to address the following topics, across a range of common diseases:
- The state of the art in gene identification strategies
- The transition from knowledge of susceptibility genes to understanding of mechanisms
- Population genetics and genome evolution in common disease genetics
- The utility of risk prediction based on genetic and other available tests
- Ethical, legal and social implications of personal genetic information
The Genomics of Common Diseases 2008
-
Organizers
- Timothy Aitman (Imperial College London, UK)
- David Altshuler (Broad Institute of MIT and Harvard, USA)
- Richard Gibbs (Baylor College of Medicine, USA)
- Leena Peltonen (The Wellcome Trust Sanger Institute, UK)
- Eddy Rubin (Lawrence Berkeley National Laboratory, USA)
- Kyle Vogan (Nature Genetics, USA)
-
Date
September 6-9, 2008
-
Venue Location
The Broad Institute of MIT and Harvard, Cambridge, MA, USA
